ITEM METADATA RECORD
Title: Myeloid-derived suppressor cells in glioma
Authors: Mirghorbani, Masoud ×
Van Gool, Stefaan
Rezaei, Nima #
Issue Date: Dec-2013
Publisher: Expert Reviews Ltd.
Series Title: Expert Review of Neurotherapeutics vol:13 issue:12 pages:1395-406
Article number: 10.1586/14737175.2013.857603
Abstract: Glioblastoma is the most prevalent form of gliomas with high aggressive nature and high recurrence. Despite aggressive therapy, including surgery, chemotherapy and radiotherapy, median patient survival is only about 15 months. Hence, developing novel and efficient therapies seem urgent. Many fields have begun their work in preclinical studies but gained limited success in clinical phases. One of the most notable reasons is tumor-induced immunosuppression. In recent decade, efforts to dissect this immunosuppressive network have been done vastly. In a number of malignancies such as glioma, myeloid-derived suppressor cells (MDSCs) have been shown to infiltrate malignant tissues having critical role in the network. Many studies, most of them on lab models, were conducted to understand how MDSCs take part in immunosuppression. Here, we reviewed MDSC relations with other immunocellular components like T cell and natural killer cell.
URI: 
ISSN: 1473-7175
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Pediatric Immunology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy

 




All items in Lirias are protected by copyright, with all rights reserved.

© Web of science